This study shows evidence of sub-clinical nerve degeneration with regeneration following treatment with the GLP-1 agonist semaglutide in two children with a MC4R gene mutation and severe obesity. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.